Literature DB >> 2139581

Fluorescence studies on calmodulin binding to erythrocyte Ca2(+)-ATPase in different oligomerization states.

D Kosk-Kosicka1, T Bzdega, J D Johnson.   

Abstract

The fluorescent spinach calmodulin derivative 2-(4-maleimidoanilino)naphthalene-6-sulfonic acid-calmodulin (MIANS-CaM) was used to investigate calmodulin interaction with the purified, detergent-solubilized erythrocyte Ca2(+)-ATPase. Previous studies have shown that the Ca2(+)-ATPase exists in equilibria between monomeric and oligomeric forms. We report here that MIANS-CaM binds to both enzyme forms in a Ca2(+)-dependent manner, with a approximately 50% fluorescence enhancement. These findings confirm our previous observation that enzyme oligomers retain their ability to bind calmodulin, even though they are fully activated in the absence of calmodulin. The Ca2+ dependence of MIANS-CaM binding to monomeric Ca2(+)-ATPase is of higher affinity (K 1/2 = 0.09 microM Ca2+) and less cooperative (nH = 1.1) than the Ca2+ dependence of enzyme activation by MIANS-CaM (K 1/2 = 0.26 microM Ca2+, nH = 2.8). These Ca2+ dependences and the order of events, in which calmodulin binding precedes enzyme activation, demonstrate that calmodulin indeed could be a physiological activator of the monomeric enzyme. The calcium dependence of calmodulin binding to oligomeric Ca2(+)-ATPase occurs at even lower levels of Ca2+ (K 1/2 = 0.04 microM Ca2+), in a highly cooperative fashion (nH = 2.3), and essentially in parallel with enzyme activation (K 1/2 = 0.05 microM Ca2+, nH = 2.9). The observed differences between monomers and oligomers suggest that the oligomerized Ca2(+)-ATPase is in a conformation necessary for efficient, cooperative calcium binding at nanomolar Ca2+, which the monomeric enzyme acquires only upon interaction with calmodulin.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2139581     DOI: 10.1021/bi00459a030

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  8 in total

1.  Site-specific amino acid alterations in Ca2+ binding domains in calmodulin impair activation of RBC Ca(2+)-ATPase.

Authors:  D Kosk-Kosicka; T Bzdega; A Wawrzynow; D M Watterson; T J Lukas
Journal:  Biophys J       Date:  1992-04       Impact factor: 4.033

Review 2.  Recent advances in the molecular characterization of plasma membrane Ca2+ pumps.

Authors:  E E Strehler
Journal:  J Membr Biol       Date:  1991-02       Impact factor: 1.843

3.  Protein kinase C and calmodulin effects on the plasma membrane Ca2+-ATPase from excitable and nonexcitable cells.

Authors:  D Kosk-Kosicka; L Zylińska
Journal:  Mol Cell Biochem       Date:  1997-08       Impact factor: 3.396

4.  Plasma membrane calcium ATPase activity is regulated by actin oligomers through direct interaction.

Authors:  Marianela G Dalghi; Marisa M Fernández; Mariela Ferreira-Gomes; Irene C Mangialavori; Emilio L Malchiodi; Emanuel E Strehler; Juan Pablo F C Rossi
Journal:  J Biol Chem       Date:  2013-06-26       Impact factor: 5.157

5.  Stimulation of plasma membrane Ca2+ -pump ATPase of vascular smooth muscle by cGMP-dependent protein kinase: functional reconstitution with purified proteins.

Authors:  Y Yoshida; A Toyosato; M O Islam; T Koga; S Fujita; S Imai
Journal:  Mol Cell Biochem       Date:  1999-01       Impact factor: 3.396

6.  Neutral organic solute effects on the activity of the plasma membrane Ca(2+)-ATPase.

Authors:  D Kosk-Kosicka; G Roszczyńska
Journal:  Mol Cell Biochem       Date:  1994-11-23       Impact factor: 3.396

7.  Inhibition of the calcium pump by high cytosolic Ca2+ in intact human red blood cells.

Authors:  A C Pereira; D Samellas; T Tiffert; V L Lew
Journal:  J Physiol       Date:  1993-02       Impact factor: 5.182

8.  Stabilizing and destabilizing effects on plasma membrane Ca(2+)-ATPase activity.

Authors:  D Kosk-Kosicka; A Wawrzynow; G Roszczynska
Journal:  Mol Cell Biochem       Date:  1994-10-12       Impact factor: 3.396

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.